Skip to main content

Table 2 Graft function and dialysis early post-transplantation

From: rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial

 

rhEPO-b group (n = 19)

Placebo group (n =20)

RR (CI) p

Primary non-function

0

0

 

Delayed graft function n (%)

10 (53%)

11 (55%)

RR = 1.0 (0.5-1.6) p = 0.93

Slow graft function n (%)

6 (32%)

5 (25%)

RR = 1.1 (0.5-1.9) p = 0.73

Days to first dialysis*

1 (1-3)

1 (1-3)

 

Number of dialysis episodes*

3 (1-17)

4 (1-19)

 

Days to last dialysis*

7 (1-41)

8 (1-35)

 
  1. *median (IQR).